Incyte Corp. (INCY)
127.99
+0.18
(+0.14%)
USD |
NASDAQ |
Aug 24, 16:00
127.99
0.00 (0.00%)
After-Hours: 19:20
Incyte Debt to Equity Ratio : 0.006 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.006 |
| March 31, 2026 | 0.007 |
| December 31, 2025 | 0.0106 |
| September 30, 2025 | 0.0089 |
| June 30, 2025 | 0.0102 |
| March 31, 2025 | 0.0118 |
| December 31, 2024 | 0.0175 |
| September 30, 2024 | 0.0115 |
| June 30, 2024 | 0.0125 |
| March 31, 2024 | 0.0069 |
| December 31, 2023 | 0.0101 |
| September 30, 2023 | 0.0077 |
| June 30, 2023 | 0.0084 |
| March 31, 2023 | 0.009 |
| December 31, 2022 | 0.0127 |
| September 30, 2022 | 0.01 |
| June 30, 2022 | 0.0107 |
| March 31, 2022 | 0.0114 |
| December 31, 2021 | 0.016 |
| September 30, 2021 | 0.0186 |
| June 30, 2021 | 0.0207 |
| March 31, 2021 | 0.0217 |
| December 31, 2020 | 0.0236 |
| September 30, 2020 | 0.0296 |
| June 30, 2020 | 0.0323 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0369 |
| December 31, 2019 | 0.0277 |
| September 30, 2019 | 0.0307 |
| June 30, 2019 | 0.0331 |
| March 31, 2019 | 0.0202 |
| December 31, 2018 | 0.0091 |
| September 30, 2018 | 0.0138 |
| June 30, 2018 | 0.0142 |
| March 31, 2018 | 0.0149 |
| December 31, 2017 | 0.0147 |
| September 30, 2017 | 0.0135 |
| June 30, 2017 | 0.0228 |
| March 31, 2017 | 0.0431 |
| December 31, 2016 | 1.553 |
| September 30, 2016 | 1.739 |
| June 30, 2016 | 2.139 |
| March 31, 2016 | 2.756 |
| December 31, 2015 | 3.622 |
| September 30, 2015 | 7.031 |
| June 30, 2015 | 11.96 |
| March 31, 2015 | -16.84 |
| December 31, 2014 | -8.442 |
| September 30, 2014 | -8.150 |
| June 30, 2014 | -3.938 |
| March 31, 2014 | -4.096 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Mirum Pharmaceuticals, Inc. | -73.21 |
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
| BioMarin Pharmaceutical, Inc. | 0.6672 |
| Eli Lilly & Co. | 1.621 |
| Biogen, Inc. | 0.4433 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.873B |
| Total Liabilities (Quarterly) | 1.528B |
| Shareholders Equity (Quarterly) | 6.344B |
| Current Ratio | 4.593 |
| Net Debt Paydown Yield | 0.00% |